Atlas Trials

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Clinical trial NCT01705106 · TERMINATED

Trial details

NCT number
NCT01705106
Sponsor
University of Chicago
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2012-08-29
Primary completion
2016-02-10
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.